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Abstract
Background: The death of a child before or shortly after birth is frequently preceded by an end-of-life decision
(ELD). Population-based studies of incidence and characteristics of ELDs in neonates and infants are rare, and those
in the foetal-infantile period (> 22 weeks of gestation – 1 year) including both neonates and stillborns, are non-
existent. However, important information is missed when decisions made before birth are overlooked. Our study
protocol addresses this knowledge gap.
Methods: First, a new and encompassing framework was constructed to conceptualise ELDs in the foetal-infantile
period. Next, a population mortality follow-back survey in Flanders (Belgium) was set up with physicians who
certified all death certificates of stillbirths from 22 weeks of gestation onwards, and infants under the age of
a year. Two largely similar questionnaires (stillbirths and neonates) were developed, pilot tested and validated,
both including questions on ELDs and their preceding decision-making processes. Each death requires a postal
questionnaire to be sent to the certifying physician. Anonymity of the child, parents and physician is ensured by
a rigorous mailing procedure involving a lawyer as intermediary between death certificate authorities, physicians
and researchers. Approval by medical societies, ethics and privacy commissions has been obtained.
Discussion: This research protocol is the first to study ELDs over the entire foetal-infantile period on a population
level. Based on representative samples of deaths and stillbirths and applying a trustworthy anonymity procedure,
the research protocol can be used in other countries, irrespective of legal frameworks around perinatal end-of-life
decision-making.
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Background
Recent decades have seen an increase in possible med-
ical and technical interventions for critically ill neonates
and infants [1]. However, in Flanders, Belgium about 8.7
per thousand children still die during the foetal-infantile
period, i.e. from foetuses of more than 500 g or 22 weeks
of gestation up until 1 year after birth [2]. This is com-
parable with death rates reported, for instance, in the
United States [3]. Many of these deaths occur at
neonatal intensive care units (NICUs) and are preceded
by a possibly life-shortening end-of-life decision (ELD)
[4–6]. In neonates, these include non-treatment deci-
sions such as withholding or withdrawing life-sustaining
treatment, intensification of alleviation of pain and/or
other symptoms with a potential life-shortening effect
and intentionally ending life with lethal drugs [7]. Add-
itionally, prenatal diagnostic techniques (genetic tech-
niques, prenatal imaging techniques) have evolved
considerably, leading to an increasing number of con-
genital malformations being diagnosed prenatally instead
of after birth [8, 9]. Some decisions such as abstinence
from treatment [8–10] or termination of pregnancy
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(TOP) [8, 9] can be made during gestation in cases of
the detection of serious abnormalities [11–13]. For still-
births from 22 weeks of gestation and onwards –
which is considered as the definition of a viable
foetus by the WHO – TOPs are considered late ter-
minations. Stillborns and deceased neonates cannot
be seen as separate patient populations, since they are
in essence the same patient where an ELD can be
made either before or after birth. The only difference
is therefore the occurrence of birth and not necessar-
ily a difference in disorders or congenital anomalies.
Research into end-of-life decision-making on a population
level should therefore take into account the
foetal-infantile period in its entirety (instead of both pe-
riods separately). This is needed to provide reliable inci-
dence rates and information on the decision-making
process in this vulnerable population. Evaluation and
monitoring of ELD practice in the entire foetal-infantile
period could lead to better understanding of current pre-
natal and neonatal health care and detect points of im-
provement since there have been no all-inclusive
guidelines up to the present.
Population-based studies (i.e. with all death cases as
the focus) are ideal to study the incidence and character-
istics of ELDs, but such studies are rare in neonates and
infants [14–16] and, to our knowledge, non-existent in
stillborns. In neonates, results are mostly based on re-
views of medical records of a NICU at a particular hos-
pital. In these studies 40 to 93% of deaths in a NICU
follow withdrawal of life-sustaining treatments [6, 17–
19]. The larger scale EURONIC study was based on phy-
sicians’ self-reported practices within 143 European
NICUs in the 1990s [20]. The only population-based
studies are from the Netherlands (in 2014) [15] and
Belgium (in 2000) [14]. These studies found an ELD be-
ing made in 60% of all deaths of neonates and infants. In
stillborns, previous studies in 2003 [11] and in 2000–
2005 [13] have only looked at the prevalence of late
TOP [11, 13, 21]. Not much is known about the entirety
of end-of-life practices (including decisions other than
TOP) and their decision-making process, or about pa-
tient characteristics besides gestational age and the pres-
ence of foetal anomalies.
We developed a study design to evaluate and monitor
ELDs and their decision-making process across the en-
tire foetal-infantile period in Flanders, Belgium. The
study design involves the development of a validated
conceptual framework of ELDs spanning the entire
foetal-infantile period (based on existing frameworks)
and the development of a survey methodology that ad-
dresses the particular difficulties in capturing and sur-
veying stillbirths and neonatal deaths, and provides
opportunities for comparison of ELD practices between
hospitals.
Methods
This population study has the design of a mortality
follow-back survey based on all death certificates of
stillbirths and neonates. Questionnaires are either sent
to the certifying physicians by post or are provided at
maternity wards. In order to develop these question-
naires, adjustments to an existing neonatal ELD
framework needed to be made.
Conceptual framework of foetal-infantile ELDs
Prenatal ELDs should be taken into account when pre-
senting a reliable and complete picture on foetal-infantile
ELD practices. However, to date these prenatal ELDs have
not been included in a comprehensive framework with
neonatal ELDs. We adjusted a previously existing and vali-
dated framework of ELDs in neonates [7] in order to in-
clude both prenatal and neonatal ELDs. This framework
[7] includes three dimensions: ‘medico-technical‘, ‘medi-
co-ethical’ and ‘consultation with parents’. The dimension
‘consultation with parents’ was excluded from our own
framework since no decision can be made prenatally with-
out at least the mother consenting to an intervention. Fur-
thermore, the dimension ‘consultation with patients’ is
also excluded from the adult ELD framework where the
medical decision and its intention are the only determi-
nants of an ELD. However, this dimension is still very im-
portant which is why consultation with parents will still
be addressed in detail by means of additional questions
outside the ELD framework. These encompass the
following:
1. The medico-technical classification or medical acts
[7, 22]:
– non-treatment decisions such as withholding or
withdrawal of life-sustaining treatment
– administering drugs or medical interventions
2. The medico-ethical classification or the life-
shortening intention of the physician can be [7, 14]:
– no intention but taking into account a potentially
life-shortening effect
– the potentially life-shortening effect is not the main
goal but partly intended (co-intention)
– an explicit life-shortening intention.
To cover all possible decisions that could possibly in-
fluence the death of a foetus or infant, both dimensions
should be taken into consideration. As a side note,
intentionally ending the life of a child is illegal, meaning
that in this case, the medico-ethical dimension is
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considered to be all the more important since no em-
phasis is put on the medico-technical classification
specifically.
We presented this framework for validation to
gynaecologists in eight individual interviews and two
expert panels representing seven different hospitals.
The gynaecologists were asked to give clinical exam-
ples for all possible ELD categories applied to the
prenatal context, and to add more categories in case
any were missing. As soon as a realistic example was
given and agreed on by others, that ELD was consid-
ered possible and included in the framework (Table 1).
The resulting foetal-infantile ELD framework was
then thoroughly reviewed by three neonatologists.
Literature on end-of-life practices prior to stillbirth
distinguishes between non-aggressive obstetric manage-
ment and TOP [9, 10, 23]. Non-aggressive obstetric
management (or abstinence from treatment) is the de-
nial of interventions which are needed to sustain the life
of the foetus because of a poor foetal prognosis [8–10].
TOP however, actively ends foetal life [8, 9] by preterm
induction of labour either with or without feticide (ad-
ministering medication to intentionally end the life of
the foetus before birth) prior to the termination [24].
Questionnaires
Based on this adjusted framework, two separate but
similar questionnaires were developed for ELDs in
stillborns and ELDs in neonates respectively, since
both populations have their own specificities. Both
questionnaires include questions about ELDs, the
decision-making process, the involvement of parents
in this process, the involvement of colleagues and ex-
perts, and the ELD policy of the hospital.
For neonates and infants, previously validated ques-
tionnaires that focus on end-of-life decisions in minors
and neonates [14, 16, 25] were used as the basis for our
questionnaire. We mainly focused on updating the terms
and grammar used, term ambiguity, length of the ques-
tionnaire and comparability to the previous ELD study
[14]. The resulting questionnaire was thoroughly pilot
tested and validated with eight neonatologists who
Table 1 A comprehensive framework of end-of-life practices in the foetal-infantile period
Indicated in grey: not valid in the prenatal context. NTD: non-treatment decisions, APS: alleviation of pain and/or symptoms, LI: lethal interventions. This table only
includes medical interventions to the child or foetus
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represented all eight Flemish NICUs, researchers in the
field of end-of-life care and an ethicist.
For ELDs in stillborns a new questionnaire was devel-
oped based on previously validated questionnaires on
TOP after 22 weeks [11, 12], questionnaires on ELDs in
minors and neonates [14, 16, 26], and the newly devel-
oped framework for end-of-life practices in the
foetal-infantile period. This questionnaire was thor-
oughly pilot tested and validated with eight gynaecolo-
gists, three neonatologists, researchers in the field of
end-of-life care, an ethicist and a lawyer in the field of
end-of-life care.
Neither questionnaire asks directly about categories
of ELDs but classifies these based on a series of core
questions following the two dimensions of the concep-
tual framework about 1) which act or omission was
used (medico-technical), and 2) which life-shortening
intention was associated with the act (medico-ethical).
Additional questions were asked about the ways in
which parents were involved in the decision-making
process (parent consultation).
Population and setting
The population includes: all stillbirths from 22 weeks of
gestation or more and/or a birthweight of 500 g or
higher (i.e. the internationally acknowledged limit of via-
bility of the foetus [24, 27, 28]) and all deceased neo-
nates and infants under the age of 1 year occurring in
Flanders and Brussels where the mother is a Flemish
resident. No sample is drawn; the full population is in-
cluded over a data collection period of 12 months for
stillbirths and 16 months for neonates and infants. The
longer observation period for neonate and infant deaths
was chosen because these deaths are less common than
late termination stillbirths [2] and we wanted to obtain a
population large enough to make reliable prevalence es-
timates of end-of-life practices.
Deaths to be included in the study are identified using
the death certificate. Every death of a Flemish resident in
Flanders and Brussels must be declared by means of a
death certificate to the Flemish Agency for Care and
Health of the Ministry of the Flemish Community or the
Brussels Health and Social Observatory respectively. The
physician, in our study most probably a neonatologist,
paediatrician or gynaecologist, completes the main part
of the death certificate which indicates the sex of the
child, the date of birth and the date of death, medical in-
formation such as the cause of death, whether or not the
child was alive at the time of birth, and the time and
place of death [29]. The physician then signs the certifi-
cate and adds his or her medical registration number.
The death certificate is then sent to the civil registrar of
the municipality where the death took place where add-
itional information is completed on the death certificate
such as socio-demographic information about the child
and its parents. Certificates are then processed by the
provinces before being sent to the central administration
authorities. It can take up to 3 months for death certifi-
cates to reach these administration authorities.
Design and procedures
A mortality follow-back procedure is followed, slightly
modifying well-established procedures in adults [22]
and minors [26]. Modifications concern a more strin-
gent anonymity procedure and an alternative identifi-
cation procedure for stillbirths between 22 and
26 weeks. As for the anonymity procedure, ethical
and legal considerations (criminal prosecution is pos-
sible for reported illegal ELDs) make it necessary to
pay greater attention to the protection of confidential-
ity of the physician, to the privacy of the deceased,
the parents and the relatives, and to the security of
the data that will be obtained in the survey. By ensur-
ing total anonymity, both the response rate and the
reliability of the responses can be improved. The dif-
ferent stages of the survey i.e. the mailing, receiving
and processing of the questionnaires will be separated
and performed by four separate entities (see Fig. 1).
1. The death certificate administration authorities
(namely Flemish Agency for Care and Health of the
Ministry of Welfare, Health and Family of the
Flemish Government) is responsible for
construction and management of the mailing
database and the mailing of the questionnaires.
Each case is ascribed a unique coded number
derived from the death certificate number. These
unique numbers are used at the end of the study to
link the questionnaires to the demographic and
morbidity data (such as ICD-10 codes of the cause
of death) of the deceased, derived from the death
certificates, in a database provided by the adminis-
tration authorities. An accompanying letter is in-
cluded with the questionnaire providing the
physician with enough patient characteristics to
identify the patient. These include sex, date of
(still)birth, date of death and municipality of death;
for stillborns the date of death is replaced by the
date of birth of the mother. When the lawyer (see
below) receives the questionnaire he or she reports
back to the Flemish Agency for Care and Health; all
identifiable data related to the patient and the phys-
ician in question is then removed from the study
database. A follow-up mailing of three reminders is
performed 14, 28 and 42 days after the initial ques-
tionnaire was sent (following the Total Design
Method [30]).
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2. The physician identifies the deceased or stillborn
child based on the patient characteristics provided,
fills out the questionnaires and returns these to a
lawyer using a postage paid envelope. In case the
certifying physician is not the treating or attending
physician he or she is given specific instructions to
pass the questionnaire to the treating physician if
possible.
3. The lawyer, who is bound by confidentiality,
safeguards the anonymity of the questionnaires. He
or she codes the participating hospital wards so that
comparisons can be made, and removes any
possible identifying information of hospital,
physician or patient, removes the unique numbers
and reports these to the administration authorities.
Additionally, place of death will not be sent to the
researchers in order to ensure anonymity of the
participating hospitals. The lawyer links the
questionnaires with the information on the database
from the death certificate administration
authorities, and at the end of the data collection
sends the linked database to the researcher group in
which all identifiers will be removed and
information can no longer be traced back to the
corresponding death certificate.
4. The research group receives questionnaires and
ensures that both in processing and analysing the
database it will not be possible to determine the
identity of the patient or the physician.
An alternative identification procedure for stillbirths
between 22 and 26 weeks is included because the death
certificate method proves to be challenging for stillbirths
in that age group. Filling in death certificates of still-
births between 22 and 26 weeks of gestation by a phys-
ician is not mandatory, which makes the death
certificates a potentially incomplete sampling frame-
work. We provided questionnaires to the ten biggest ma-
ternity wards in Flanders and the Flemish hospitals of
Brussels so that physicians can fill out this questionnaire
for every stillbirth from 22 weeks of gestation onwards
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- Prepares database of stillborn
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- Replaces hospital number with new number
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corresponding new numbers
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- Replaces sample numbers in the database of
stillborn characteristics with corresponding new
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- Replaces hospital numbers in the database of
stillborn characteristics with corresponding new
numbers
- Assists in small cells risk analysis before the
database is sent to the research group
1
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- Combines questionnaire data and corresponding
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6
Questionnaires + database
of stillborn characteristics +
anonymized NIC/MIC
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Fig. 1 Schematic overview of the mailing and anonymity procedure
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These maternity wards were chosen based on the pres-
ence of a NICU at the hospital, because of a high birth
rate and/or because they are tertiary centres for prenatal
diagnostics. For each stillbirth for which a questionnaire
is completed, the physician is also asked to fill out a
death certificate. This makes it possible for the lawyer to
link the answers in the questionnaire to the clinical and
demographic characteristics of the stillborn child (for a
schematic overview of this procedure, see Fig. 2). The
physician sends the questionnaire, together with a separ-
ate letter containing patient identification details to the
lawyer and sends the certificate to the official death cer-
tificate agency. Because the latter sends patient identifi-
cation details of death certificates for stillbirths to the
lawyer, the lawyer can then determine whether a ques-
tionnaire has already been received for that death and
notify the Flemish agency for Care and Health via email.
In this case, no questionnaires are sent by the death
certificate agency. The separate letter with patient identi-
fication details is destroyed as soon as the questionnaire
is linked to the corresponding death certificate. If a
physician did not fill out the questionnaire available in
the maternity ward but did file a death certificate, they
will still receive a questionnaire through the regular pos-
tal survey.
Improving response rates
To increase response, we follow the Total Design
Method (TDM) [30]. Therefore, physicians will receive a
maximum of three follow-up postal mailings. In order to
further improve the response rate both in stillborns and
in neonates and infants we will add an additional general
follow-up. Every 3 to 4 months one of the researchers
will visit all eight Flemish NICUs and all ten participat-
ing maternity wards to inquire about the course of the
study. During visits, physicians will be able to ask
Physician
Signs death certificate
Fills out questionnaire +
letter with separate patient
identification details
Flemish Agency for Care and 
Health
- Samples every received
death certificate indicating a
stillbirth
- Sends patient identification
details of every certified
stillbirth together with the
unique and anonymous
sample number to the lawyer
- Manages survey database
- Prepares database of
stillborn characteristics
Lawyer
- Save patient identification details in a
separate database until the data can
be anonymized
- Receive identification details of every
certified stillbirth from the Flemish
Agency for Care and Health
- Send unique sample number of
already received questionnaires back
to the Flemish Agency for Care and
Health
- Writes new number (corresponding
with unique sample number) on
questionnaire
- Manages database of received sample
numbers and corresponding new
numbers
- Keeps received questionnaires until
end of survey
- Replaces unique sample numbers in
the database of stillborn characteristics
with corresponding new numbers
- Assists in small cells risk analysis














- Combines questionnaire data and corresponding














Fig. 2 Schematic overview of the parallel procedure in the ten biggest maternity wards
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questions, voice concerns or give general feedback.
These visits are also meant to counter responder fatigue
by stimulating motivation for the study duration. Fur-
thermore, three consortium meeting will be organised to
discuss the progress of the study with representatives of
every NICU (one before the start, one half way through
and one at the end of the study). Lastly, the study is also
presented at relevant conferences and meetings.
Ethical aspects and data protection
The sensitivity of the research population and the deli-
cate nature of our questionnaire makes it necessary to
follow a rigorous ethical approval procedure. Ethics ap-
proval was obtained from the ethics committee of the
University Hospital of Ghent and additionally from the
Privacy Commission (CBPL), the Sectoral Committee of
Social Security and Health, and the National Council of
the Order of Physicians. For our parallel procedure in
the ten biggest maternity wards, we obtained ethics ap-
proval from the ethics committees of all participating
hospitals.
To ensure privacy and anonymity, as well as the pre-
cautions that have already be taken by using a lawyer, we
strive to ensure full data protection. The data are always
password protected and stored on a protected server.
The database is not replicated or shared with third par-
ties; all copies needed for analysis are destroyed
afterwards.
Data-analysis
An SPSS 24.0 (SPSS Inc.) file is set up by the research
group with a coding scheme for a certified data manage-
ment company that will enter the data. The researchers
will perform all data cleaning through SPSS syntax oper-
ations. Data will be analysed with descriptive statistics
(valid percentages and 95% confidence intervals), bivari-
ate and multivariate association statistics.
Discussion
The objectives of this population study are to evaluate
and monitor ELDs and their decision-making process in
the foetal-infantile period including ELDs in the foetal
and the neonatal period. This study design has several
potential strengths as well as some limitations associated
with the study population and the survey method.
Strengths
Our study is the first to examine foetal-infantile ELDs in
their entirety. The results will broaden knowledge on
which medical decisions are made in cases of congenital
anomalies or severe disorders from the moment of via-
bility, regardless of whether or not the child has been
born. Even though ELDs have been researched both pre-
natally [11, 13, 21] and in neonates [14, 16, 31], the
continuity of care and the overarching decision-making
process has been missed in previous studies and there-
fore key elements (such as whether the ELD was made
prenatally but performed after the child is born) could
be overlooked.
Even though there are some studies comparing late
TOP practices across European countries [11, 13, 21],
not much is known about the full scope of end-of-life
practices before birth (including non-treatment deci-
sions) and their decision-making process. However,
non-treatment decisions such as non-aggressive obstet-
ric management with or without explicit intention to
shorten the life of the foetus can also occur. One of the
strengths of our study is therefore the inclusion of all
types of possible ELDs in neonates and also before birth.
Furthermore, even when the child died postnatally we
inquire about decisions being made prenatally and
thereby provide a full overview of ELDs without prior
focus on one specific ELD.
Most research on ELDs in prenatal [11, 13] and neo-
natal [6, 17, 20] settings is limited to single centre stud-
ies and based on reviews of medical records.
Population-based studies based on officially registered
death certificates, like ours, are however far more cap-
able of obtaining robust data and reliable incidence rates
since a nationwide scope ensures that the entire popula-
tion is included. These could in turn lead to better un-
derstanding of current end-of-life care and detect points
of improvement to benefit future parents and children
with severe disorders. The only population-based study
on Belgian neonatal ELDs dates back to 2000 [14] and
since then, important societal changes such as question-
ing futile medical end-of-life care and refuting the idea
of curative treatment as being necessarily beneficial
could possibly have had an effect on end-of-life practice
in unborn babies and neonates [32].
Aside from population specific strengths, some
strengths can be attributed to the death certificate
method in particular. These include international com-
parability, lack of patient burden and consequent attri-
tion rates, reliability of the data, anonymity, and
exclusion of possible selection bias by selecting certain
physicians for the study. An overview of the strengths
related to the death certificate method, which has suc-
cessfully been implemented in adults [33], minors [26]
and neonates [14], can be found in the research protocol
of Chambaere et al. [29].
Limitations
One of the weaknesses of the study is that the death cer-
tificate method provides a challenge in the case of still-
birth between 22 and 26 weeks of gestation because
completing a death certificate is not mandatory at this
age. Despite our added data collection method, we
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cannot guarantee 100% coverage of stillbirths. Neverthe-
less, the reports from the Flemish centre of Perinatal Epi-
demiology, which registers every birth, will be available
after the study and will make it possible to estimate the
number of missing cases. Furthermore, despite the add-
itional data collection method there is also no way to en-
sure that physicians will always complete a death
certificate (as it is not obligatory), even when they fill out
the questionnaire. It is therefore possible that we will
receive questionnaires which we are not able to link to a
death certificate which will therefore be unusable for this
study.
Delays in the processing of death certificates can reach
up to 4 months before the questionnaire is sent to the
physician in the first method [29]. Therefore, a recall
bias cannot be excluded. However, no other registration
of deaths up to the age of 1 year exists and the only
other registration of all births (live and stillbirths) occurs
at the Flemish centre of Perinatal Epidemiology. This
consists of fewer missing cases, however, and the delay
in processing these documents can be up to 1 year
which would drastically decrease the reliability of the re-
sponses. Furthermore, this method of registration is due
to be merged with the existing death certificate registra-
tion, making our method the most reliable for future
trend research.
We include all stillbirths from 22 weeks of gestation
onwards because this is internationally acknowledged to
be the limit of viability of the foetus [24, 27, 28]. How-
ever, some congenital anomalies can be detected before
this viability threshold so we cannot exclude an ELD
having been made before the 22 weeks cut-off used in
this study. Furthermore, most Flemish neonatology
wards only consider viability from 24, 25 or even
26 weeks of gestation which could also have an impact
on whether or not a death certificate is filled out.
Implications for future research and practice
Regular repetition of this study in the future is needed in
order to monitor and evaluate changes in end-of-life
practices in the foetal-infantile group. Because this study
design allows application in other countries, we recom-
mend international comparative studies to provide us
with better insight into foetal-infantile end-of-life prac-
tices and incidence rates so that international foetal and
neonatal care at the end of life can be optimised.
This can eventually aid the development of obstetrical,
neonatal and paediatric guidelines to support an ethical
end-of-life decision-making process.
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